Press Release regarding unaudited financial results for Q3 FY 26
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
05-Feb-2026
Download PDF
Marksans Pharma
Press Release regarding unaudited financial results for Q3 FY 26
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]